Bruno Julianne
- SEC CIK
- 0002019645
No open-market purchases or sales filed in the past year.
Current role at each company
- DMRA Damora Therapeutics, Inc.Directoras of Mar 25, 2026
- CRSP CRISPR Therapeutics AGChief Operating Officeras of Mar 24, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bruno Julianne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRSP CRISPR Therapeutics AG
Chief Operating Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Bruno JulianneChief Operating Officer | SSale | −1.71K | $41.23 | −$70.7K | −14.0%10.5K after | |
| Mar 12, 2025 (view filing) | Mar 11-12 | 1 day | Bruno JulianneChief Operating Officer | SSale | −1.39K | $42.54 | −$59.0K | −14.0%8.51K after | 2 lots |
| Feb 19, 2025 (view filing) | Feb 19 | Same day | Bruno JulianneChief Operating Officer | SSale | −333 | $52.80 | −$17.6K | −4.5%7.06K after | |
| Jun 24, 2024 (view filing) | Jun 21 | 3 days | Bruno JulianneChief Operating Officer | SSale | −3.37K | $56.09 | −$188.8K | −33.3%6.75K after |